Triaziquone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2,3,5-tris(aziridin-1-yl)benzo-1,4-quinone | |
| Identifiers | |
| CAS Number |
68-76-8 |
| ATC code | L01AC02 (WHO) |
| PubChem | CID 6235 |
| ChemSpider |
5999 |
| UNII |
F3D5D9P25I |
| KEGG |
C19542 |
| ChEBI |
CHEBI:27090 |
| Synonyms | 2,3,5-Tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione |
| Chemical data | |
| Formula | C12H13N3O2 |
| Molar mass | 231.25 g/mol |
| |
| |
| | |
Triaziquone is a drug used in chemotherapy.
It is an alkylating agent.[1] It can react with DNA to form intrastrand crosslinks.
References
- ↑ Begleiter A (2000). "Clinical applications of quinone-containing alkylating agents". Front. Biosci. 5: E153–71. doi:10.2741/A483. PMID 11056078.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
